Next Article in Journal
UCHL1 Promotes Gastric Cancer Progression by Regulating CIP2A Degradation
Previous Article in Journal
Comparative Risk of Complications Following Intestinal Surgery After Infliximab, Vedolizumab, or Ustekinumab Treatment: Systematic Review & Meta-Analysis
Previous Article in Special Issue
Innovative Wound Healing Strategy Through Amorphization of Active Pharmaceutical Ingredients as an Effective Approach for Hydrogel Formulation
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(10), 1467; https://doi.org/10.3390/ph18101467
Action Date Notes Link
article xml file uploaded 29 September 2025 16:25 CEST Original file -
article xml uploaded. 29 September 2025 16:25 CEST Update https://www.mdpi.com/1424-8247/18/10/1467/xml
article pdf uploaded. 29 September 2025 16:25 CEST Version of Record https://www.mdpi.com/1424-8247/18/10/1467/pdf
article html file updated 29 September 2025 16:26 CEST Original file https://www.mdpi.com/1424-8247/18/10/1467/html
Back to TopTop